Browse > Article

Comparison of polyethylene glycol 4000 and lactulose for treatment of chronic functional constipation in children  

Uhm, Ji Hyun (Department of Pediatrics, College of Medicine, Eulji University)
Publication Information
Clinical and Experimental Pediatrics / v.50, no.8, 2007 , pp. 752-756 More about this Journal
Abstract
Purpose : The aim of this study was to compare 2 laxatives, namely, polyethylene glycol 4000 without electrolytes and lactulose, evaluating the efficacy and safety for the treatment of constipation in children. Methods : Fifty-six children with chronic functional constipation were randomly assigned to receive polyethylene glycol 4000 (24 patients) or lactulose (32 patients). Patients or their parents reported defecation frequency, stool consistency, abdominal pain, stool incontinence and side effects after 1, 3, 6 and 12 months of treatment. Percentage of recovered patients were compared with each group. Results : Defecation frequency, abdominal pain and stool incontinence were improved in each group. At 12 months of follow up, 60% of patients treated with polyethylene glycol and 57.7% of patients treated with lactulose were considered as recovered. Conclusion : In this study, both polyethylene glycol and lactulose were equally effective and safe in the long-term treatment of constipation in children. There were no significant differences in recovery rates between 2 groups.
Keywords
Constipation; Children; Polyethylene glycol;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Loening-Baucke V, Krishna R, Pashankar DS. Polyethylene glycol 3350 without electrolytes for the treatment of functional constipation in infants and toddlers. J Pediatr Gastroenterol Nutr 2004;39:536-9   DOI   ScienceOn
2 Youssef NN, Peters JM, Henderson W, Shultz-Peters S, Lockhart DK, Di Lorenzo C. Dose response of PEG 3350 for treatment of childhood fecal impaction. J Pediatr 2002;141: 410-4   DOI   ScienceOn
3 Loening-Baucke V. Factors responsible for persistence of childhood constipation. J Pediatr Gastroenterol Nutr 1987;6: 915-22   DOI
4 Chung KS. Chronic constipation in children. Korean J Pediatr 2004;47(3 suppl):631S-42S
5 Gremse DA, Hixon J, Crutchfield A. Comparison of polyethylene glycol 3350 and lactulose for treatment of chronic constipation in children. Clin Pediatr 2002;41:225-9   DOI
6 Voskuijl W, de Lorijn F, Verwijs W, Hogeman P, Heijmans J, Makel W, et al. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Gut 2004;53:1590-4   DOI   ScienceOn
7 van Ginkel R, Reitsma JB, Buller HA, van Wijk MP, Taminiau JA, Benninga MA. Childhood constipation: longitudinal follow-up beyond puberty. Gastroenterology 2003;125: 357-63   DOI   ScienceOn
8 Canning DA. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children. J Urol 2003;170:327
9 Loening-Baucke V. Factors determining outcome in children with chronic constipation and faecal soiling. Gut 1989;30:999-1006   DOI
10 Rasquin-Weber A, Hyman PE, Cucchiara S, Fleisher DR, Hyams JS, Milla PJ, et al. Childhood functional gastrointestinal disorders. Gut 1999;45(Suppl 2):60-8
11 Dupont C, Leluyer B, Maamri N, Morali A, Joye JP, Fiorini JM, et al. Double-Blind randomized evaluation of clinical and biological tolerance of Polyethylene glycol 4000 versus lactulose in constipated children. J Pediatr Gastroenterol Nutr 2005;41:625-33   DOI   ScienceOn
12 Lewis G, Rudolph CD. Practical approach to defecation disorders in children. Pediatr Ann 1997;26:260-8   DOI
13 Pashankar D, Bishop WP. Efficacy and optimal dose of daily polyethylene glycol 3350 for treatment of constipation and encopresis in children. J Pediar Gastroenterol Nutr 2001;139: 428-32
14 Loening-Baucke V. Polyethylene glycol without electrolytes for children with constipation and encopresis. J Pediatr Gastroenterol Nutr 2002;34:372-7   DOI   ScienceOn
15 Hudziak H, Bronowicki JP, Frank P, Dubos-Berogin C, Bigard MA. Low dose of Polyethylene glycol 4000: digestive effects. Randomazed double-blind study in healthy subjects. Gastroenterol Clin Biol 1996;20:418-23
16 Baker SS, Liptak GS, Colletti RB, Croffie JM, Di Lorenzo C, Ector W, et al. Constipation in infants and children: evaluation and treatment. A medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 1999;28:612-26
17 Loening-Baucke V, Pashankar DS. A randomized, prospective, comparison study of Polyethylene glycol 3350 without electrolytes and milk of magnesia for children with constipation and fecal incontinence. J pediatr 2006;118:528-35   DOI   ScienceOn
18 Attar A, Lemann M, Ferguson A, Halphen M, Boutron MC, Flourie B, et al. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut 1999;44:226-30   DOI   ScienceOn
19 Benninga MA, Voskuijl WP, Taminiau JA. Childhood constipation: is there new light in the tunnel? J Pediatr Gastroenterol Nutr 2004;39:448-64   DOI   ScienceOn
20 DiPalma JA, DeRidder PH, Orlando RC, Kolts BE, Cleveland MB. A randomized, placebo-controlled, multicenter study of the safety and efficacy of a new polyethylene glycol laxative. Am J Gastroenterol 2000;95:446-50   DOI   ScienceOn
21 Candy DC, Edwards D, Geraint M. Treatment of faecal impaction with polyethelene glycol plus electrolytes (PGE+E) followed by a double-blind comparison of PEG+E versus lactulose as maintenance therapy. J Pediatr Gastroenterol Nutr 2006;43:65-70   DOI   ScienceOn
22 de Lorijn F, van Wijk MP, Reitsma JB, van Ginkel R, Taminiau JA, Benninga MA. Prognosis of constipation: clinical factors and colonic transit time. Arch Dis Child 2004;89:723-7   DOI   ScienceOn
23 Xing JH, Soffer EE. Adverse effects of laxatives. Dis Colon Rectum 2001;44:1201-9   DOI   ScienceOn
24 Dupont C, Leluyer B, Amar F, Kalach N, Benhamou PH, Mouterde O, et al. A dose determination study of polyethylene glycol 4000 in constipated children: factors influencing the maintenance dose. J Pediatr Gastroenterol Nutr 2006;42: 178-85   DOI   ScienceOn
25 Voskuijl WP, Heijmans J, Heijmans HS, Taminiau JA, Benninga MA. Use of Rome II criteria in childhood defecation disorders: applicability in clinical and research practice. J Pediatr 2004;145:213-7   DOI   ScienceOn